APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nanoemulsions

Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).

There are several advantages of nanoemulsions over the conventional emulsion systems. One of the major advantages is the extreme micro droplet size of nanoemulsions with much high surface area which makes them highly effective in transportation system or delivery systems used majorly in cosmetics. Moreover, nanoparticles do not cause the problems such as flocculation, coalescence or inherent creaming which are generally faced by microemulsions. This makes nanoemulsions ideal for variety of formulations such creams, sprays and foams.

Considering the extreme small size of these particles, the nanoemulsions are increasingly finding application in pharmaceutical industry, cosmetic industry and also in food sector. The pharmaceutical applications of nanoemulsions majorly dominate the nanoemulsions market, followed by the cosmetic usages. Currently, the market for nanoemulsions is dominated by North America and Europe. Asia Pacific is the fastest growing market for nanoemulsions.

Selected research

Market Outlook & Growth Opportunities

Global Nanoemulsions Market Outlook and Growth Opportunities 2026

21 December 2025199 pages

Choose your research edition.

Industry ResearchNanoemulsions Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Nanoemulsions Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Nanoemulsions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nanoemulsions Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Nanoemulsions Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).

There are several advantages of nanoemulsions over the conventional emulsion systems. One of the major advantages is the extreme micro droplet size of nanoemulsions with much high surface area which makes them highly effective in transportation system or delivery systems used majorly in cosmetics. Moreover, nanoparticles do not cause the problems such as flocculation, coalescence or inherent creaming which are generally faced by microemulsions. This makes nanoemulsions ideal for variety of formulations such creams, sprays and foams.

Considering the extreme small size of these particles, the nanoemulsions are increasingly finding application in pharmaceutical industry, cosmetic industry and also in food sector. The pharmaceutical applications of nanoemulsions majorly dominate the nanoemulsions market, followed by the cosmetic usages. Currently, the market for nanoemulsions is dominated by North America and Europe. Asia Pacific is the fastest growing market for nanoemulsions.

Read the full market overview

In USA, EU, Japan, China, India and Southeast Asia, Nanoemulsions key players include Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, etc.

USA is the largest market, with a share over 35%, followed by Europe, and Japan, both have a share about 40 percent.

In terms of application, the largest application is Pharmaceutical Industrial, with a share over 45%, followed by Cosmetic Industrial, Food Industrial, etc.

This report provides an overview of the global Nanoemulsions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nanoemulsions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nanoemulsions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Nanoemulsions market.

Nanoemulsions Segment by Company

Allergan plc

AbbVie Inc.

AstraZeneca Inc.

Fresenius Kabi AG

Kaken Pharmaceutical

GlaxoSmithKline

Novartis AG

Sanofi

B. Braun Melsungen

Nanoemulsions Segment by Type

Steroids

Anesthetics

NSAIDs

Immunosuppressant

Antiretroviral

Antimicrobials

Vasodilators

Others

Nanoemulsions Segment by Application

Pharmaceutical Industrial

Cosmetic Industrial

Food Industrial

Others

Nanoemulsions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nanoemulsions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Nanoemulsions key companies, revenue, market share, and recent developments.

3. To split the Nanoemulsions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Nanoemulsions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nanoemulsions significant trends, drivers, influence factors in global and regions.

6. To analyze Nanoemulsions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanoemulsions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nanoemulsions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanoemulsions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nanoemulsions industry.

Chapter 3: Detailed analysis of Nanoemulsions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Nanoemulsions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Nanoemulsions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nanoemulsions Industry Trends Table 2. Nanoemulsions Industry Drivers Table 3. Nanoemulsions Industry Opportunities and Challenges Table 4. Nanoemulsions Industry Restraints Table 5. Global Nanoemulsions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nanoemulsions Revenue Share by Company (2021-2026) Table 7. Global Nanoemulsions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Nanoemulsions Key Company Manufacturing Base & Headquarters Table 9. Global Nanoemulsions Company, Product Type & Application Table 10. Global Nanoemulsions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Nanoemulsions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Steroids Table 15. Significant Companies of Anesthetics Table 16. Significant Companies of NSAIDs Table 17. Significant Companies of Immunosuppressant Table 18. Significant Companies of Antiretroviral Table 19. Significant Companies of Antimicrobials Table 20. Significant Companies of Vasodilators Table 21. Significant Companies of Others Table 22. Global Nanoemulsions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 23. Global Nanoemulsions Sales Value by Type (2021-2026) & (US$ Million) Table 24. Global Nanoemulsions Sales Value by Type (2027-2032) & (US$ Million) Table 25. Global Nanoemulsions Sales Value Share by Type (2021-2026) Table 26. Global Nanoemulsions Sales Value Share by Type (2027-2032) Table 27. Significant Companies of Pharmaceutical Industrial Table 28. Significant Companies of Cosmetic Industrial Table 29. Significant Companies of Food Industrial Table 30. Significant Companies of Others Table 31. Global Nanoemulsions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Nanoemulsions Sales Value by Application (2021-2026) & (US$ Million) Table 33. Global Nanoemulsions Sales Value by Application (2027-2032) & (US$ Million) Table 34. Global Nanoemulsions Sales Value Share by Application (2021-2026) Table 35. Global Nanoemulsions Sales Value Share by Application (2027-2032) Table 36. Global Nanoemulsions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Nanoemulsions Sales Value by Region (2021-2026) & (US$ Million) Table 38. Global Nanoemulsions Sales Value Share by Region (2021-2026) Table 39. Global Nanoemulsions Sales Value by Region (2027-2032) & (US$ Million) Table 40. Global Nanoemulsions Sales Value Share by Region (2027-2032) Table 41. Global Nanoemulsions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Nanoemulsions Sales Value by Country (2021-2026) & (US$ Million) Table 43. Global Nanoemulsions Sales Value Market Share by Country (2021-2026) Table 44. Global Nanoemulsions Sales Value by Country (2027-2032) & (US$ Million) Table 45. Global Nanoemulsions Sales Value Market Share by Country (2027-2032) Table 46. Allergan plc Company Information Table 47. Allergan plc Business Overview Table 48. Allergan plc Nanoemulsions Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Allergan plc Nanoemulsions Product Portfolio Table 50. Allergan plc Recent Development Table 51. AbbVie Inc. Company Information Table 52. AbbVie Inc. Business Overview Table 53. AbbVie Inc. Nanoemulsions Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. AbbVie Inc. Nanoemulsions Product Portfolio Table 55. AbbVie Inc. Recent Development Table 56. AstraZeneca Inc. Company Information Table 57. AstraZeneca Inc. Business Overview Table 58. AstraZeneca Inc. Nanoemulsions Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. AstraZeneca Inc. Nanoemulsions Product Portfolio Table 60. AstraZeneca Inc. Recent Development Table 61. Fresenius Kabi AG Company Information Table 62. Fresenius Kabi AG Business Overview Table 63. Fresenius Kabi AG Nanoemulsions Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Fresenius Kabi AG Nanoemulsions Product Portfolio Table 65. Fresenius Kabi AG Recent Development Table 66. Kaken Pharmaceutical Company Information Table 67. Kaken Pharmaceutical Business Overview Table 68. Kaken Pharmaceutical Nanoemulsions Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Kaken Pharmaceutical Nanoemulsions Product Portfolio Table 70. Kaken Pharmaceutical Recent Development Table 71. GlaxoSmithKline Company Information Table 72. GlaxoSmithKline Business Overview Table 73. GlaxoSmithKline Nanoemulsions Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. GlaxoSmithKline Nanoemulsions Product Portfolio Table 75. GlaxoSmithKline Recent Development Table 76. Novartis AG Company Information Table 77. Novartis AG Business Overview Table 78. Novartis AG Nanoemulsions Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Novartis AG Nanoemulsions Product Portfolio Table 80. Novartis AG Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Nanoemulsions Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sanofi Nanoemulsions Product Portfolio Table 85. Sanofi Recent Development Table 86. B. Braun Melsungen Company Information Table 87. B. Braun Melsungen Business Overview Table 88. B. Braun Melsungen Nanoemulsions Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. B. Braun Melsungen Nanoemulsions Product Portfolio Table 90. B. Braun Melsungen Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Nanoemulsions Product Image Figure 2. Global Nanoemulsions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nanoemulsions Market Size (2021-2032) & (US$ Million) Figure 4. Global Nanoemulsions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Steroids Image Figure 8. Anesthetics Image Figure 9. NSAIDs Image Figure 10. Immunosuppressant Image Figure 11. Antiretroviral Image Figure 12. Antimicrobials Image Figure 13. Vasodilators Image Figure 14. Others Image Figure 15. Global Nanoemulsions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Nanoemulsions Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Nanoemulsions Sales Value Share by Type (2021-2032) Figure 18. Pharmaceutical Industrial Image Figure 19. Cosmetic Industrial Image Figure 20. Food Industrial Image Figure 21. Others Image Figure 22. Global Nanoemulsions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Nanoemulsions Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Nanoemulsions Sales Value Share by Application (2021-2032) Figure 25. Global Nanoemulsions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 26. Global Nanoemulsions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 27. North America Nanoemulsions Sales Value (2021-2032) & (US$ Million) Figure 28. North America Nanoemulsions Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Europe Nanoemulsions Sales Value (2021-2032) & (US$ Million) Figure 30. Europe Nanoemulsions Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Asia-Pacific Nanoemulsions Sales Value (2021-2032) & (US$ Million) Figure 32. Asia-Pacific Nanoemulsions Sales Value Share by Country (%), 2025 VS 2032 Figure 33. South America Nanoemulsions Sales Value (2021-2032) & (US$ Million) Figure 34. South America Nanoemulsions Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Middle East & Africa Nanoemulsions Sales Value (2021-2032) & (US$ Million) Figure 36. Middle East & Africa Nanoemulsions Sales Value Share by Country (%), 2025 VS 2032 Figure 37. USA Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. USA Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. USA Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Canada Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Canada Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Canada Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Mexico Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Mexico Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Mexico Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Germany Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Germany Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Germany Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. France Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. France Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. France Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. U.K. Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. U.K. Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. U.K. Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Italy Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Italy Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Italy Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Spain Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Spain Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Spain Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Russia Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Russia Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Russia Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Netherlands Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Netherlands Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Netherlands Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Nordic Countries Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Nordic Countries Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Nordic Countries Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. China Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. China Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. China Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Japan Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Japan Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Japan Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. South Korea Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. South Korea Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. South Korea Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. India Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. India Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. India Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Australia Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Australia Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Australia Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Southeast Asia Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Southeast Asia Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Southeast Asia Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Brazil Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Brazil Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Brazil Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Argentina Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Argentina Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Argentina Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Chile Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Chile Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Chile Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Colombia Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Colombia Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Colombia Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Peru Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Peru Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Peru Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Saudi Arabia Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Israel Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Israel Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Israel Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. UAE Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. UAE Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. UAE Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Turkey Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Turkey Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Turkey Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Iran Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Iran Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Iran Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Egypt Nanoemulsions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Egypt Nanoemulsions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Egypt Nanoemulsions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Years Considered Figure 122. Research Process Figure 123. Key Executives Interviewed

Scope & coverage.

Types
  • Steroids
  • Anesthetics
  • NSAIDs
  • Immunosuppressant
  • Antiretroviral
  • Antimicrobials
  • Vasodilators
  • Others
Applications
  • Pharmaceutical Industrial
  • Cosmetic Industrial
  • Food Industrial
  • Others
Companies covered
  • Allergan plc
  • AbbVie Inc.
  • AstraZeneca Inc.
  • Fresenius Kabi AG
  • Kaken Pharmaceutical
  • GlaxoSmithKline
  • Novartis AG
  • Sanofi
  • B. Braun Melsungen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nanoemulsions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nanoemulsions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Nanoemulsions Market Dynamics
  1. 2.1 Nanoemulsions Industry Trends
  2. 2.2 Nanoemulsions Industry Drivers
  3. 2.3 Nanoemulsions Industry Opportunities and Challenges
  4. 2.4 Nanoemulsions Industry Restraints
3 Nanoemulsions Market by Company
  1. 3.1 Global Nanoemulsions Company Revenue Ranking in 2025
  2. 3.2 Global Nanoemulsions Revenue by Company (2021-2026)
  3. 3.3 Global Nanoemulsions Company Ranking (2024-2026)
  4. 3.4 Global Nanoemulsions Company Manufacturing Base and Headquarters
  5. 3.5 Global Nanoemulsions Company Product Type and Application
  6. 3.6 Global Nanoemulsions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Nanoemulsions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Nanoemulsions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Nanoemulsions Market by Type
  1. 4.1 Nanoemulsions Type Introduction
  2. 4.1.1 Steroids
  3. 4.1.2 Anesthetics
  4. 4.1.3 NSAIDs
  5. 4.1.4 Immunosuppressant
  6. 4.1.5 Antiretroviral
  7. 4.1.6 Antimicrobials
  8. 4.1.7 Vasodilators
  9. 4.1.8 Others
  10. 4.2 Global Nanoemulsions Sales Value by Type
  11. 4.2.1 Global Nanoemulsions Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Nanoemulsions Sales Value by Type (2021-2032)
  13. 4.2.3 Global Nanoemulsions Sales Value Share by Type (2021-2032)
5 Nanoemulsions Market by Application
  1. 5.1 Nanoemulsions Application Introduction
  2. 5.1.1 Pharmaceutical Industrial
  3. 5.1.2 Cosmetic Industrial
  4. 5.1.3 Food Industrial
  5. 5.1.4 Others
  6. 5.2 Global Nanoemulsions Sales Value by Application
  7. 5.2.1 Global Nanoemulsions Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Nanoemulsions Sales Value by Application (2021-2032)
  9. 5.2.3 Global Nanoemulsions Sales Value Share by Application (2021-2032)
6 Nanoemulsions Regional Value Analysis
  1. 6.1 Global Nanoemulsions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nanoemulsions Sales Value by Region (2021-2032)
  3. 6.2.1 Global Nanoemulsions Sales Value by Region: 2021-2026
  4. 6.2.2 Global Nanoemulsions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nanoemulsions Sales Value (2021-2032)
  7. 6.3.2 North America Nanoemulsions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Nanoemulsions Sales Value (2021-2032)
  10. 6.4.2 Europe Nanoemulsions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Nanoemulsions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Nanoemulsions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Nanoemulsions Sales Value (2021-2032)
  16. 6.6.2 South America Nanoemulsions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Nanoemulsions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Nanoemulsions Sales Value Share by Country, 2025 VS 2032
7 Nanoemulsions Country-level Value Analysis
  1. 7.1 Global Nanoemulsions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nanoemulsions Sales Value by Country (2021-2032)
  3. 7.2.1 Global Nanoemulsions Sales Value by Country (2021-2026)
  4. 7.2.2 Global Nanoemulsions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Nanoemulsions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Nanoemulsions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Nanoemulsions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Nanoemulsions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Nanoemulsions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Nanoemulsions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Nanoemulsions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Nanoemulsions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Nanoemulsions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Nanoemulsions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Nanoemulsions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Nanoemulsions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Nanoemulsions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Nanoemulsions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Nanoemulsions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Nanoemulsions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Nanoemulsions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Nanoemulsions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Nanoemulsions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Nanoemulsions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Nanoemulsions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Nanoemulsions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Nanoemulsions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Nanoemulsions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Nanoemulsions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Nanoemulsions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Nanoemulsions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Nanoemulsions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Nanoemulsions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Nanoemulsions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Nanoemulsions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Allergan plc
  2. 8.1.1 Allergan plc Company Information
  3. 8.1.2 Allergan plc Business Overview
  4. 8.1.3 Allergan plc Nanoemulsions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Allergan plc Nanoemulsions Product Portfolio
  6. 8.1.5 Allergan plc Recent Developments
  7. 8.2 AbbVie Inc.
  8. 8.2.1 AbbVie Inc. Company Information
  9. 8.2.2 AbbVie Inc. Business Overview
  10. 8.2.3 AbbVie Inc. Nanoemulsions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AbbVie Inc. Nanoemulsions Product Portfolio
  12. 8.2.5 AbbVie Inc. Recent Developments
  13. 8.3 AstraZeneca Inc.
  14. 8.3.1 AstraZeneca Inc. Company Information
  15. 8.3.2 AstraZeneca Inc. Business Overview
  16. 8.3.3 AstraZeneca Inc. Nanoemulsions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Inc. Nanoemulsions Product Portfolio
  18. 8.3.5 AstraZeneca Inc. Recent Developments
  19. 8.4 Fresenius Kabi AG
  20. 8.4.1 Fresenius Kabi AG Company Information
  21. 8.4.2 Fresenius Kabi AG Business Overview
  22. 8.4.3 Fresenius Kabi AG Nanoemulsions Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fresenius Kabi AG Nanoemulsions Product Portfolio
  24. 8.4.5 Fresenius Kabi AG Recent Developments
  25. 8.5 Kaken Pharmaceutical
  26. 8.5.1 Kaken Pharmaceutical Company Information
  27. 8.5.2 Kaken Pharmaceutical Business Overview
  28. 8.5.3 Kaken Pharmaceutical Nanoemulsions Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kaken Pharmaceutical Nanoemulsions Product Portfolio
  30. 8.5.5 Kaken Pharmaceutical Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Nanoemulsions Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Nanoemulsions Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Novartis AG
  38. 8.7.1 Novartis AG Company Information
  39. 8.7.2 Novartis AG Business Overview
  40. 8.7.3 Novartis AG Nanoemulsions Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Novartis AG Nanoemulsions Product Portfolio
  42. 8.7.5 Novartis AG Recent Developments
  43. 8.8 Sanofi
  44. 8.8.1 Sanofi Company Information
  45. 8.8.2 Sanofi Business Overview
  46. 8.8.3 Sanofi Nanoemulsions Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi Nanoemulsions Product Portfolio
  48. 8.8.5 Sanofi Recent Developments
  49. 8.9 B. Braun Melsungen
  50. 8.9.1 B. Braun Melsungen Company Information
  51. 8.9.2 B. Braun Melsungen Business Overview
  52. 8.9.3 B. Braun Melsungen Nanoemulsions Revenue and Gross Margin (2021-2026)
  53. 8.9.4 B. Braun Melsungen Nanoemulsions Product Portfolio
  54. 8.9.5 B. Braun Melsungen Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst